New Strategies for the Treatment of Older Myeloma Patients
Multiple myeloma (MM) mostly affects older patients, who represent a highly heterogeneous population. In the last few years, the introduction of novel agents led to a significant improvement in the outcome of MM patients. Nonetheless, this positive trend is less likely to occur in all older patients...
Main Authors: | Alessandra Larocca, Lorenzo Cani, Giuseppe Bertuglia, Benedetto Bruno, Sara Bringhen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/10/2693 |
Similar Items
-
Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma Patients
by: Francesca Bonello, et al.
Published: (2020-10-01) -
Three Drug Combinations in the Treatment of Fit Elderly Multiple Myeloma Patients
by: Hélène Gardeney, et al.
Published: (2020-11-01) -
Frail Multiple Myeloma Patients Deserve More Than Just a Score
by: Hannah Louise Miller, et al.
Published: (2023-02-01) -
Contemporary Analysis of Electronic Frailty Measurement in Older Adults with Multiple Myeloma Treated in the National US Veterans Affairs Healthcare System
by: Clark DuMontier, et al.
Published: (2021-06-01) -
Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma?
by: Giuseppe Bertuglia, et al.
Published: (2022-12-01)